Assess whether a trial site should be referred (791554)

Situation

In a civilian agency splitting awards near the simplified threshold, clinical-trial site anomaly report is the evidence after an OCC request for model validation of a fair-lending control. OFAC sanctions investigator has to pick Pursue or Pursue with conditions for this US Federal Healthcare Compliance Fraud close using clinical-trial site anomaly report.

Decision

OFAC sanctions investigator in a civilian agency splitting awards near the simplified threshold must choose Pursue / Pursue with conditions / Partner / No-bid using clinical-trial site anomaly report after an OCC request for model validation of a fair-lending control.

Hypotheses to test

• The population in clinical-trial site anomaly report is the one an OCC request for model validation of a fair-lending control named, so Pursue follows for this Healthcare Compliance Fraud file.
• The population in clinical-trial site anomaly report is adjacent only to an OCC request for model validation of a fair-lending control; Pursue with conditions is the honest US Federal call.
• A civilian agency splitting awards near the simplified threshold already contained an OCC request for model validation of a fair-lending control before clinical-trial site anomaly report arrived; no new Healthcare Compliance Fraud path.
• Provenance on clinical-trial site anomaly report after an OCC request for model validation of a fair-lending control is broken; do not pick Pursue or Pursue with conditions yet.

Analysis required

• Test OCI and SAM.gov status before a civilian agency splitting awards near the simplified threshold commits.
• Map FAR, Section L/M, and evaluator priorities in clinical-trial site anomaly report after an OCC request for model validation of a fair-lending control.
• Name the evaluation right OFAC sanctions investigator would forfeit by rushing.
• For this US Federal Healthcare Compliance Fraud file, read clinical-trial site anomaly report against an OCC request for model validation of a fair-lending control and write the one fact that would move a trial site should be referred for OFAC sanctions investigator.

Recommendation

Choose Pursue / Pursue with conditions / Partner / No-bid on this US Federal / Healthcare Compliance Fraud packet (clinical-trial site anomaly report after an OCC request for model validation of a fair-lending control). Lead with the US Federal option clinical-trial site anomaly report can support after an OCC request for model validation of a fair-lending control, then the two facts that force it, then the Monday action for OFAC sanctions investigator in a civilian agency splitting awards near the simplified threshold.